T2DM involves multiple disorders, including of lipid and glucose metabolism, β-cell dysfunction, chronic low-grade inflammation, and oxidative stress, which result in insulin resistance and insufficient insulin secretion (Tangvarasittichai, 2015; Gutierrez-Rodelo et al., 2017). The gene discussed is INS; the disease is Insulin resistance.